Cancer NetworkOriginal article
<![CDATA[Monitoring and Managing CRS, ICANS, and Infections With Bispecifics]]>
bispecificsNeutral
AI Analysis
Summary
Dr. Ralph V. Boccia discusses clinical management strategies for patients receiving bispecific antibodies, including remote monitoring, ICE scoring, cytokine release syndrome prophylaxis, and intravenous immunoglobulin strategies.
Importance:2/10
Sentiment:
0.00
bispecific antibodiescytokine release syndromeCRSICANSmonitoringsafety managementclinical practice
Read the original article
Published by Cancer Network on October 12, 2026 2:00 PM
